Tag: ADC manufacturing
Opportunities for ADC Development and Manufacturing
At the 2022 World ADC Conference in San Diego, Stewart Mitchell, Executive Vice President and site head of Sterling Pharma Solutions' Deeside, U.K. facility, presented a case study on the development and GMP manufacture at the site.
A New Horizon in ADC Technology: A Panel Discussion
Targeted therapies such as antibody-drug conjugates (ADC) have opened new ways in targeting diseases like cancer and hematological malignancies. High-potent active pharmaceutical ingredients, also...
How a CDMO can Support ADC Manufacturing
Over the last decades, outsourcing of pharmaceutical development and manufacturing, driven by a variety of factors, has resulted in the growth of Contract Development...
Creating a New Single-digit Nanogram Containment Manufacturing Facility: MilliporeSigma Announces US...
In a statement today, MilliporeSigma, the Life Science business of Merck KGaA, Darmstadt, Germany, confirmed a US $65 million (€ 59 million) investment in...
Download the Application Note on the Pellicon® Capsule
Tangential flow filtration (TFF) is essential in the manufacturing of antibody drug conjugates (ADCs). Ultrafiltration (UF) is used to concentrate the protein product and...
Investing for the Future: Unlocking Advanced ADC Manufacturing Innovation
UPDATE: This event has been postponed until Fall 2019.
Investment in ADCs (antibody-drug conjugates) has surged due to some very compelling market trends that include: ...
ADC Biotechnology Secures UK £1.14 million Investment
ADC Biotechnology has successfully secured UK £1.14 million in funding from, Downing LLP, a London-based investment management firm.
The company, founded in 2010, is developing...
Ajinomoto Althea Expected to Open New Manufacturing Facility for Antibody-drug Conjugate...
Biopharmaceutical contract development and manufacturing services company, Ajinomoto Althea confirmed that announced it will soon open a GMP production suite in its newly constructed...
Lonza – Celebrating 10 Years as ADC Manufacturing Pioneer
By leveraging the company's experience in biopharmaceuticals and small molecule drug process development and scale-up, Lonza has been successful in manufacturing antibody-drug conjugates, a...
Contract Manufacturing of Antibody-drug Conjugates – A Growing Market
The demand for manufacturing capacity of antibody-drug conjugates (ADCs), which includes a highly potent cytotoxic drug linked to a monoclonal antibody and have shown to...
